An internal standard for the quantification of balsalazide
Related Products
Unlabeled Version(s)
18680Balsalazide
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Balsalazide-d4

Item No. 28888

Technical Information
Formal Name
(E)-5-((4-((2-carboxyethyl)carbamoyl)phenyl-2,3,5,6-d4)diazenyl)-2-hydroxybenzoic acid
Molecular Formula
C17H11D4N3O6
Formula Weight
Purity
≥99% deuterated forms (d1-d4)
A solid
DMSO: solubleMethanol: soluble
SMILES
OC1=CC=C(/N=N/C2=C([2H])C([2H])=C(C(NCCC(O)=O)=O)C([2H])=C2[2H])C=C1C(O)=O
InChi Code
InChI=1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26)/b20-19+/i1D,2D,3D,4D
InChi Key
IPOKCKJONYRRHP-AAMHWJAJSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Balsalazide-d4 is intended for use as an internal standard for the quantification of balsalazide (Item No. 18680) by GC- or LC-MS. Balsalazide is a prodrug form of 5-aminosalicylic acid (5-ASA; Item No. 70265).1 It is cleaved by bacterial azoreductases in the intestinal lumen to release 5-ASA. Balsalazide (600 mg/kg per day) decreases IL-2 levels and increases IL-6 levels in the serum and colonic mucosa membrane, as well as decreases micro- and macroscopic colonic damage, in a rat model of colitis induced by 2,4-dinitrochlorobenzene (DNCB).2 Formulations containing balsalazide have been used in the treatment of ulcerative colitis.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Tursi, A. Balsalazide in treating colonic diseases. Expert Opin. Drug Metab. Toxicol. 5(12), 1555-1563 (2009).

    2. Lu, Y.-X., and Chen, X.-M. Effects of balsalazide on experimental colitis induced by 2,4-dinitrochlorobenzene in rats. Zhongguo Xinyao Yu Linchuang Zazhi 26(12), 901-904 (2007).